isnt ACTHAR sold only in the US at present?
what is necessary to start selling ACTHAR globally?
ps it sure seems to me QCOR has only scratched the service, especially when viewed on a "global" potential
Well they hired the guy to start that process last quarter and there were already some clinical trials started in Germany. It's a great big unknown right now, like anything that just started, but they will update us on what this new exec is doing during the earning call.
I was just thinking the same. I know it is a process to introduce drugs globally. If there was suddenly a deluge of demand, does QCOR have the capabilities to fill?....what a terrible problem this could be. Maybe they raise the price to $34k/ vial.